1. Home
  2. FVCB vs NVRO Comparison

FVCB vs NVRO Comparison

Compare FVCB & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FVCB
  • NVRO
  • Stock Information
  • Founded
  • FVCB 2007
  • NVRO 2006
  • Country
  • FVCB United States
  • NVRO United States
  • Employees
  • FVCB N/A
  • NVRO N/A
  • Industry
  • FVCB Major Banks
  • NVRO Medical/Dental Instruments
  • Sector
  • FVCB Finance
  • NVRO Health Care
  • Exchange
  • FVCB Nasdaq
  • NVRO Nasdaq
  • Market Cap
  • FVCB 248.5M
  • NVRO 214.2M
  • IPO Year
  • FVCB N/A
  • NVRO 2014
  • Fundamental
  • Price
  • FVCB $11.05
  • NVRO $5.73
  • Analyst Decision
  • FVCB
  • NVRO Hold
  • Analyst Count
  • FVCB 0
  • NVRO 12
  • Target Price
  • FVCB N/A
  • NVRO $7.24
  • AVG Volume (30 Days)
  • FVCB 16.2K
  • NVRO 1.7M
  • Earning Date
  • FVCB 01-23-2025
  • NVRO 02-28-2025
  • Dividend Yield
  • FVCB N/A
  • NVRO N/A
  • EPS Growth
  • FVCB 290.48
  • NVRO N/A
  • EPS
  • FVCB 0.82
  • NVRO N/A
  • Revenue
  • FVCB $58,117,000.00
  • NVRO $419,146,000.00
  • Revenue This Year
  • FVCB N/A
  • NVRO N/A
  • Revenue Next Year
  • FVCB N/A
  • NVRO $0.23
  • P/E Ratio
  • FVCB $13.48
  • NVRO N/A
  • Revenue Growth
  • FVCB 42.12
  • NVRO N/A
  • 52 Week Low
  • FVCB $9.78
  • NVRO $3.17
  • 52 Week High
  • FVCB $14.50
  • NVRO $16.12
  • Technical
  • Relative Strength Index (RSI)
  • FVCB 35.78
  • NVRO 70.16
  • Support Level
  • FVCB $12.22
  • NVRO $4.77
  • Resistance Level
  • FVCB $12.41
  • NVRO $5.80
  • Average True Range (ATR)
  • FVCB 0.42
  • NVRO 0.13
  • MACD
  • FVCB -0.09
  • NVRO -0.01
  • Stochastic Oscillator
  • FVCB 1.57
  • NVRO 93.20

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About NVRO Nevro Corp.

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Share on Social Networks: